nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—SLCO1A2—Prednisolone—multiple sclerosis	0.0962	0.128	CbGbCtD
Enalapril—SLCO1A2—Prednisone—multiple sclerosis	0.0908	0.121	CbGbCtD
Enalapril—SLC22A7—Methotrexate—multiple sclerosis	0.065	0.0867	CbGbCtD
Enalapril—SLCO1A2—Dexamethasone—multiple sclerosis	0.0567	0.0757	CbGbCtD
Enalapril—SLCO1A2—Methotrexate—multiple sclerosis	0.0456	0.0608	CbGbCtD
Enalapril—ABCB1—Methylprednisolone—multiple sclerosis	0.0405	0.0541	CbGbCtD
Enalapril—SLC22A8—Methotrexate—multiple sclerosis	0.0397	0.0529	CbGbCtD
Enalapril—CYP3A4—Fingolimod—multiple sclerosis	0.0377	0.0503	CbGbCtD
Enalapril—ABCB1—Mitoxantrone—multiple sclerosis	0.0296	0.0394	CbGbCtD
Enalapril—SLC22A6—Methotrexate—multiple sclerosis	0.0276	0.0369	CbGbCtD
Enalapril—ABCB1—Betamethasone—multiple sclerosis	0.0263	0.0351	CbGbCtD
Enalapril—ABCB1—Prednisolone—multiple sclerosis	0.026	0.0347	CbGbCtD
Enalapril—ABCB1—Prednisone—multiple sclerosis	0.0245	0.0328	CbGbCtD
Enalapril—CYP3A4—Methylprednisolone—multiple sclerosis	0.0243	0.0324	CbGbCtD
Enalapril—CYP3A4—Triamcinolone—multiple sclerosis	0.0184	0.0245	CbGbCtD
Enalapril—CYP3A4—Mitoxantrone—multiple sclerosis	0.0177	0.0236	CbGbCtD
Enalapril—CYP3A4—Betamethasone—multiple sclerosis	0.0158	0.0211	CbGbCtD
Enalapril—CYP3A4—Prednisolone—multiple sclerosis	0.0156	0.0208	CbGbCtD
Enalapril—ABCB1—Dexamethasone—multiple sclerosis	0.0153	0.0204	CbGbCtD
Enalapril—CYP3A4—Prednisone—multiple sclerosis	0.0147	0.0196	CbGbCtD
Enalapril—ABCB1—Methotrexate—multiple sclerosis	0.0123	0.0164	CbGbCtD
Enalapril—CYP3A4—Dexamethasone—multiple sclerosis	0.00918	0.0122	CbGbCtD
Enalapril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00786	0.268	CbGpPWpGaD
Enalapril—Captopril—MMP9—multiple sclerosis	0.00136	0.107	CrCbGaD
Enalapril—Fosinopril—SLC15A2—multiple sclerosis	0.00135	0.107	CrCbGaD
Enalapril—Perindopril—SLC15A2—multiple sclerosis	0.0011	0.0871	CrCbGaD
Enalapril—Spirapril—SLC15A2—multiple sclerosis	0.00109	0.0861	CrCbGaD
Enalapril—SLC22A7—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00108	0.0369	CbGpPWpGaD
Enalapril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.00106	0.0361	CbGpPWpGaD
Enalapril—Moexipril—SLC15A2—multiple sclerosis	0.00105	0.0826	CrCbGaD
Enalapril—Quinapril—SLC15A2—multiple sclerosis	0.000972	0.0768	CrCbGaD
Enalapril—Cilazapril—SLC15A2—multiple sclerosis	0.000972	0.0768	CrCbGaD
Enalapril—Ramipril—SLC15A2—multiple sclerosis	0.000941	0.0744	CrCbGaD
Enalapril—Trandolapril—SLC15A2—multiple sclerosis	0.000941	0.0744	CrCbGaD
Enalapril—ACE—Peptide hormone metabolism—SLC30A7—multiple sclerosis	0.000892	0.0304	CbGpPWpGaD
Enalapril—Benazepril—SLC15A2—multiple sclerosis	0.000845	0.0668	CrCbGaD
Enalapril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000624	0.0212	CbGpPWpGaD
Enalapril—Perindopril—BCHE—multiple sclerosis	0.000578	0.0457	CrCbGaD
Enalapril—SLCO1A2—Transport of organic anions—ALB—multiple sclerosis	0.000527	0.018	CbGpPWpGaD
Enalapril—ACE—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	0.000514	0.0175	CbGpPWpGaD
Enalapril—Ramipril—BCHE—multiple sclerosis	0.000493	0.039	CrCbGaD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000492	0.0168	CbGpPWpGaD
Enalapril—Nateglinide—SLC15A2—multiple sclerosis	0.000487	0.0385	CrCbGaD
Enalapril—ACE—Peptide hormone metabolism—BCHE—multiple sclerosis	0.000476	0.0162	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000446	0.0152	CbGpPWpGaD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000446	0.0152	CbGpPWpGaD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000413	0.0141	CbGpPWpGaD
Enalapril—SLCO1A2—Recycling of bile acids and salts—ALB—multiple sclerosis	0.00039	0.0133	CbGpPWpGaD
Enalapril—Captopril—ALB—multiple sclerosis	0.000377	0.0298	CrCbGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000345	0.0118	CbGpPWpGaD
Enalapril—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000344	0.0117	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000295	0.01	CbGpPWpGaD
Enalapril—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000289	0.00984	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000279	0.0095	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000275	0.00936	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000275	0.00936	CbGpPWpGaD
Enalapril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000254	0.00865	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000248	0.00845	CbGpPWpGaD
Enalapril—ACE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000246	0.00839	CbGpPWpGaD
Enalapril—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000243	0.00829	CbGpPWpGaD
Enalapril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000241	0.00821	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000224	0.00762	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.00022	0.0075	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000211	0.0072	CbGpPWpGaD
Enalapril—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000209	0.001	CcSEcCtD
Enalapril—Cough—Triamcinolone—multiple sclerosis	0.000209	0.001	CcSEcCtD
Enalapril—Tachycardia—Prednisolone—multiple sclerosis	0.000207	0.000994	CcSEcCtD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000207	0.00705	CbGpPWpGaD
Enalapril—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000207	0.000992	CcSEcCtD
Enalapril—Urticaria—Mitoxantrone—multiple sclerosis	0.000205	0.000986	CcSEcCtD
Enalapril—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000205	0.000984	CcSEcCtD
Enalapril—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000204	0.000981	CcSEcCtD
Enalapril—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000204	0.000981	CcSEcCtD
Enalapril—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000204	0.00695	CbGpPWpGaD
Enalapril—Myalgia—Triamcinolone—multiple sclerosis	0.000204	0.000977	CcSEcCtD
Enalapril—Vomiting—Azathioprine—multiple sclerosis	0.000203	0.000976	CcSEcCtD
Enalapril—Pneumonia—Methotrexate—multiple sclerosis	0.000203	0.000975	CcSEcCtD
Enalapril—Arthralgia—Methylprednisolone—multiple sclerosis	0.000203	0.000974	CcSEcCtD
Enalapril—Myalgia—Methylprednisolone—multiple sclerosis	0.000203	0.000974	CcSEcCtD
Enalapril—Rash—Azathioprine—multiple sclerosis	0.000202	0.000968	CcSEcCtD
Enalapril—Dermatitis—Azathioprine—multiple sclerosis	0.000202	0.000967	CcSEcCtD
Enalapril—Depression—Methotrexate—multiple sclerosis	0.000201	0.000967	CcSEcCtD
Enalapril—Flushing—Prednisone—multiple sclerosis	0.000201	0.000966	CcSEcCtD
Enalapril—Discomfort—Triamcinolone—multiple sclerosis	0.000201	0.000965	CcSEcCtD
Enalapril—Discomfort—Methylprednisolone—multiple sclerosis	0.000201	0.000963	CcSEcCtD
Enalapril—Headache—Azathioprine—multiple sclerosis	0.0002	0.000962	CcSEcCtD
Enalapril—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.0002	0.000961	CcSEcCtD
Enalapril—Dry mouth—Triamcinolone—multiple sclerosis	0.000199	0.000955	CcSEcCtD
Enalapril—Renal failure—Methotrexate—multiple sclerosis	0.000199	0.000953	CcSEcCtD
Enalapril—Angioedema—Betamethasone—multiple sclerosis	0.000198	0.000951	CcSEcCtD
Enalapril—Angioedema—Dexamethasone—multiple sclerosis	0.000198	0.000951	CcSEcCtD
Enalapril—Stomatitis—Methotrexate—multiple sclerosis	0.000197	0.000945	CcSEcCtD
Enalapril—Conjunctivitis—Methotrexate—multiple sclerosis	0.000196	0.000942	CcSEcCtD
Enalapril—Confusional state—Methylprednisolone—multiple sclerosis	0.000196	0.000942	CcSEcCtD
Enalapril—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000195	0.00666	CbGpPWpGaD
Enalapril—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000195	0.000936	CcSEcCtD
Enalapril—Oedema—Triamcinolone—multiple sclerosis	0.000195	0.000936	CcSEcCtD
Enalapril—Vertigo—Dexamethasone—multiple sclerosis	0.000195	0.000935	CcSEcCtD
Enalapril—Vertigo—Betamethasone—multiple sclerosis	0.000195	0.000935	CcSEcCtD
Enalapril—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000195	0.000934	CcSEcCtD
Enalapril—Syncope—Betamethasone—multiple sclerosis	0.000195	0.000933	CcSEcCtD
Enalapril—Syncope—Dexamethasone—multiple sclerosis	0.000195	0.000933	CcSEcCtD
Enalapril—Arrhythmia—Prednisone—multiple sclerosis	0.000194	0.00093	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.000193	0.00658	CbGpPWpGaD
Enalapril—Shock—Triamcinolone—multiple sclerosis	0.000192	0.000921	CcSEcCtD
Enalapril—Insomnia—Prednisolone—multiple sclerosis	0.000192	0.000921	CcSEcCtD
Enalapril—Alopecia—Prednisone—multiple sclerosis	0.000192	0.00092	CcSEcCtD
Enalapril—Shock—Methylprednisolone—multiple sclerosis	0.000192	0.000919	CcSEcCtD
Enalapril—Loss of consciousness—Betamethasone—multiple sclerosis	0.000191	0.000915	CcSEcCtD
Enalapril—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000191	0.000915	CcSEcCtD
Enalapril—Epistaxis—Methotrexate—multiple sclerosis	0.000191	0.000914	CcSEcCtD
Enalapril—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000191	0.000914	CcSEcCtD
Enalapril—Paraesthesia—Prednisolone—multiple sclerosis	0.000191	0.000914	CcSEcCtD
Enalapril—Tachycardia—Triamcinolone—multiple sclerosis	0.00019	0.000914	CcSEcCtD
Enalapril—Nausea—Azathioprine—multiple sclerosis	0.00019	0.000912	CcSEcCtD
Enalapril—Tachycardia—Methylprednisolone—multiple sclerosis	0.00019	0.000912	CcSEcCtD
Enalapril—Erythema—Prednisone—multiple sclerosis	0.000189	0.000906	CcSEcCtD
Enalapril—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000189	0.000905	CcSEcCtD
Enalapril—Agranulocytosis—Methotrexate—multiple sclerosis	0.000189	0.000905	CcSEcCtD
Enalapril—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000188	0.000903	CcSEcCtD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000188	0.0064	CbGpPWpGaD
Enalapril—Asthenia—Mitoxantrone—multiple sclerosis	0.000186	0.00089	CcSEcCtD
Enalapril—Myalgia—Dexamethasone—multiple sclerosis	0.000185	0.000886	CcSEcCtD
Enalapril—Myalgia—Betamethasone—multiple sclerosis	0.000185	0.000886	CcSEcCtD
Enalapril—Discomfort—Dexamethasone—multiple sclerosis	0.000182	0.000876	CcSEcCtD
Enalapril—Discomfort—Betamethasone—multiple sclerosis	0.000182	0.000876	CcSEcCtD
Enalapril—Hypotension—Methylprednisolone—multiple sclerosis	0.000182	0.000873	CcSEcCtD
Enalapril—Hepatitis—Methotrexate—multiple sclerosis	0.000181	0.00087	CcSEcCtD
Enalapril—Pharyngitis—Methotrexate—multiple sclerosis	0.00018	0.000864	CcSEcCtD
Enalapril—Vision blurred—Prednisone—multiple sclerosis	0.000178	0.000854	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000178	0.000853	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000177	0.000851	CcSEcCtD
Enalapril—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000177	0.00085	CcSEcCtD
Enalapril—Oedema—Betamethasone—multiple sclerosis	0.000177	0.00085	CcSEcCtD
Enalapril—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000177	0.00085	CcSEcCtD
Enalapril—Oedema—Dexamethasone—multiple sclerosis	0.000177	0.00085	CcSEcCtD
Enalapril—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000177	0.000849	CcSEcCtD
Enalapril—Insomnia—Triamcinolone—multiple sclerosis	0.000176	0.000847	CcSEcCtD
Enalapril—Insomnia—Methylprednisolone—multiple sclerosis	0.000176	0.000845	CcSEcCtD
Enalapril—Paraesthesia—Triamcinolone—multiple sclerosis	0.000175	0.000841	CcSEcCtD
Enalapril—Feeling abnormal—Prednisolone—multiple sclerosis	0.000175	0.000839	CcSEcCtD
Enalapril—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000175	0.000839	CcSEcCtD
Enalapril—Visual impairment—Methotrexate—multiple sclerosis	0.000175	0.000839	CcSEcCtD
Enalapril—Anaemia—Prednisone—multiple sclerosis	0.000175	0.000838	CcSEcCtD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000174	0.00594	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000174	0.00594	CbGpPWpGaD
Enalapril—Shock—Dexamethasone—multiple sclerosis	0.000174	0.000836	CcSEcCtD
Enalapril—Shock—Betamethasone—multiple sclerosis	0.000174	0.000836	CcSEcCtD
Enalapril—Dyspnoea—Triamcinolone—multiple sclerosis	0.000174	0.000835	CcSEcCtD
Enalapril—Agitation—Prednisone—multiple sclerosis	0.000174	0.000833	CcSEcCtD
Enalapril—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000173	0.000832	CcSEcCtD
Enalapril—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000173	0.000832	CcSEcCtD
Enalapril—Tachycardia—Betamethasone—multiple sclerosis	0.000173	0.000829	CcSEcCtD
Enalapril—Tachycardia—Dexamethasone—multiple sclerosis	0.000173	0.000829	CcSEcCtD
Enalapril—Angioedema—Prednisone—multiple sclerosis	0.000173	0.000828	CcSEcCtD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000172	0.00586	CbGpPWpGaD
Enalapril—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000172	0.00586	CbGpPWpGaD
Enalapril—Dyspepsia—Triamcinolone—multiple sclerosis	0.000172	0.000824	CcSEcCtD
Enalapril—Erythema multiforme—Methotrexate—multiple sclerosis	0.000171	0.000823	CcSEcCtD
Enalapril—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000171	0.000822	CcSEcCtD
Enalapril—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000171	0.000821	CcSEcCtD
Enalapril—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000171	0.000821	CcSEcCtD
Enalapril—Vertigo—Prednisone—multiple sclerosis	0.00017	0.000814	CcSEcCtD
Enalapril—Syncope—Prednisone—multiple sclerosis	0.000169	0.000813	CcSEcCtD
Enalapril—Tinnitus—Methotrexate—multiple sclerosis	0.000169	0.000811	CcSEcCtD
Enalapril—Anorexia—Dexamethasone—multiple sclerosis	0.000169	0.00081	CcSEcCtD
Enalapril—Anorexia—Betamethasone—multiple sclerosis	0.000169	0.00081	CcSEcCtD
Enalapril—Urticaria—Prednisolone—multiple sclerosis	0.000169	0.000809	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000168	0.00574	CbGpPWpGaD
Enalapril—Fatigue—Triamcinolone—multiple sclerosis	0.000168	0.000807	CcSEcCtD
Enalapril—Fatigue—Methylprednisolone—multiple sclerosis	0.000168	0.000805	CcSEcCtD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000167	0.00568	CbGpPWpGaD
Enalapril—Loss of consciousness—Prednisone—multiple sclerosis	0.000166	0.000797	CcSEcCtD
Enalapril—Hypotension—Dexamethasone—multiple sclerosis	0.000165	0.000794	CcSEcCtD
Enalapril—Hypotension—Betamethasone—multiple sclerosis	0.000165	0.000794	CcSEcCtD
Enalapril—Vomiting—Mitoxantrone—multiple sclerosis	0.000164	0.000789	CcSEcCtD
Enalapril—Rash—Mitoxantrone—multiple sclerosis	0.000163	0.000782	CcSEcCtD
Enalapril—Dermatitis—Mitoxantrone—multiple sclerosis	0.000163	0.000782	CcSEcCtD
Enalapril—Headache—Mitoxantrone—multiple sclerosis	0.000162	0.000777	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000161	0.000774	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000161	0.000774	CcSEcCtD
Enalapril—Arthralgia—Prednisone—multiple sclerosis	0.000161	0.000772	CcSEcCtD
Enalapril—Myalgia—Prednisone—multiple sclerosis	0.000161	0.000772	CcSEcCtD
Enalapril—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000161	0.000772	CcSEcCtD
Enalapril—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00016	0.00077	CcSEcCtD
Enalapril—Alopecia—Methotrexate—multiple sclerosis	0.00016	0.000769	CcSEcCtD
Enalapril—Insomnia—Dexamethasone—multiple sclerosis	0.00016	0.000768	CcSEcCtD
Enalapril—Insomnia—Betamethasone—multiple sclerosis	0.00016	0.000768	CcSEcCtD
Enalapril—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000159	0.000764	CcSEcCtD
Enalapril—Paraesthesia—Dexamethasone—multiple sclerosis	0.000159	0.000763	CcSEcCtD
Enalapril—Paraesthesia—Betamethasone—multiple sclerosis	0.000159	0.000763	CcSEcCtD
Enalapril—Discomfort—Prednisone—multiple sclerosis	0.000159	0.000762	CcSEcCtD
Enalapril—Erythema—Methotrexate—multiple sclerosis	0.000158	0.000758	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000157	0.00536	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000157	0.00536	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000157	0.00534	CbGpPWpGaD
Enalapril—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000156	0.00533	CbGpPWpGaD
Enalapril—Hypersensitivity—Prednisolone—multiple sclerosis	0.000156	0.00075	CcSEcCtD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000156	0.00532	CbGpPWpGaD
Enalapril—Dyspepsia—Dexamethasone—multiple sclerosis	0.000156	0.000748	CcSEcCtD
Enalapril—Dyspepsia—Betamethasone—multiple sclerosis	0.000156	0.000748	CcSEcCtD
Enalapril—Urticaria—Triamcinolone—multiple sclerosis	0.000155	0.000744	CcSEcCtD
Enalapril—Urticaria—Methylprednisolone—multiple sclerosis	0.000155	0.000742	CcSEcCtD
Enalapril—Dysgeusia—Methotrexate—multiple sclerosis	0.000155	0.000742	CcSEcCtD
Enalapril—Body temperature increased—Triamcinolone—multiple sclerosis	0.000154	0.00074	CcSEcCtD
Enalapril—Anaphylactic shock—Prednisone—multiple sclerosis	0.000154	0.00074	CcSEcCtD
Enalapril—Oedema—Prednisone—multiple sclerosis	0.000154	0.00074	CcSEcCtD
Enalapril—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000154	0.000738	CcSEcCtD
Enalapril—Decreased appetite—Betamethasone—multiple sclerosis	0.000154	0.000738	CcSEcCtD
Enalapril—Decreased appetite—Dexamethasone—multiple sclerosis	0.000154	0.000738	CcSEcCtD
Enalapril—Nausea—Mitoxantrone—multiple sclerosis	0.000154	0.000737	CcSEcCtD
Enalapril—Back pain—Methotrexate—multiple sclerosis	0.000153	0.000733	CcSEcCtD
Enalapril—Fatigue—Dexamethasone—multiple sclerosis	0.000153	0.000732	CcSEcCtD
Enalapril—Fatigue—Betamethasone—multiple sclerosis	0.000153	0.000732	CcSEcCtD
Enalapril—Shock—Prednisone—multiple sclerosis	0.000152	0.000728	CcSEcCtD
Enalapril—Tachycardia—Prednisone—multiple sclerosis	0.00015	0.000722	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00015	0.00511	CbGpPWpGaD
Enalapril—Hyperhidrosis—Prednisone—multiple sclerosis	0.000149	0.000715	CcSEcCtD
Enalapril—Vision blurred—Methotrexate—multiple sclerosis	0.000149	0.000714	CcSEcCtD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000148	0.00503	CbGpPWpGaD
Enalapril—Anorexia—Prednisone—multiple sclerosis	0.000147	0.000705	CcSEcCtD
Enalapril—Anaemia—Methotrexate—multiple sclerosis	0.000146	0.0007	CcSEcCtD
Enalapril—Feeling abnormal—Betamethasone—multiple sclerosis	0.000146	0.0007	CcSEcCtD
Enalapril—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000146	0.0007	CcSEcCtD
Enalapril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000146	0.00497	CbGpPWpGaD
Enalapril—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000145	0.000695	CcSEcCtD
Enalapril—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000145	0.000695	CcSEcCtD
Enalapril—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000144	0.00069	CcSEcCtD
Enalapril—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000143	0.000688	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000143	0.00488	CbGpPWpGaD
Enalapril—Vertigo—Methotrexate—multiple sclerosis	0.000142	0.000681	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000142	0.00483	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000141	0.00482	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000141	0.00482	CbGpPWpGaD
Enalapril—Leukopenia—Methotrexate—multiple sclerosis	0.000141	0.000678	CcSEcCtD
Enalapril—Urticaria—Dexamethasone—multiple sclerosis	0.000141	0.000675	CcSEcCtD
Enalapril—Urticaria—Betamethasone—multiple sclerosis	0.000141	0.000675	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00014	0.000674	CcSEcCtD
Enalapril—Dizziness—Prednisolone—multiple sclerosis	0.00014	0.000673	CcSEcCtD
Enalapril—Asthenia—Triamcinolone—multiple sclerosis	0.00014	0.000672	CcSEcCtD
Enalapril—Abdominal pain—Betamethasone—multiple sclerosis	0.00014	0.000672	CcSEcCtD
Enalapril—Body temperature increased—Betamethasone—multiple sclerosis	0.00014	0.000672	CcSEcCtD
Enalapril—Body temperature increased—Dexamethasone—multiple sclerosis	0.00014	0.000672	CcSEcCtD
Enalapril—Abdominal pain—Dexamethasone—multiple sclerosis	0.00014	0.000672	CcSEcCtD
Enalapril—Asthenia—Methylprednisolone—multiple sclerosis	0.00014	0.00067	CcSEcCtD
Enalapril—Insomnia—Prednisone—multiple sclerosis	0.000139	0.000669	CcSEcCtD
Enalapril—Paraesthesia—Prednisone—multiple sclerosis	0.000138	0.000664	CcSEcCtD
Enalapril—Pruritus—Triamcinolone—multiple sclerosis	0.000138	0.000662	CcSEcCtD
Enalapril—Cough—Methotrexate—multiple sclerosis	0.000138	0.000661	CcSEcCtD
Enalapril—Pruritus—Methylprednisolone—multiple sclerosis	0.000138	0.000661	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—PABPC1—multiple sclerosis	0.000136	0.00464	CbGpPWpGaD
Enalapril—Dyspepsia—Prednisone—multiple sclerosis	0.000136	0.000651	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000135	0.0046	CbGpPWpGaD
Enalapril—Arthralgia—Methotrexate—multiple sclerosis	0.000134	0.000645	CcSEcCtD
Enalapril—Chest pain—Methotrexate—multiple sclerosis	0.000134	0.000645	CcSEcCtD
Enalapril—Myalgia—Methotrexate—multiple sclerosis	0.000134	0.000645	CcSEcCtD
Enalapril—Decreased appetite—Prednisone—multiple sclerosis	0.000134	0.000643	CcSEcCtD
Enalapril—Rash—Prednisolone—multiple sclerosis	0.000134	0.000642	CcSEcCtD
Enalapril—Dermatitis—Prednisolone—multiple sclerosis	0.000134	0.000641	CcSEcCtD
Enalapril—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000133	0.000639	CcSEcCtD
Enalapril—Fatigue—Prednisone—multiple sclerosis	0.000133	0.000638	CcSEcCtD
Enalapril—Headache—Prednisolone—multiple sclerosis	0.000133	0.000638	CcSEcCtD
Enalapril—Discomfort—Methotrexate—multiple sclerosis	0.000133	0.000637	CcSEcCtD
Enalapril—Constipation—Prednisone—multiple sclerosis	0.000132	0.000633	CcSEcCtD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000131	0.00447	CbGpPWpGaD
Enalapril—Confusional state—Methotrexate—multiple sclerosis	0.00013	0.000623	CcSEcCtD
Enalapril—Dizziness—Triamcinolone—multiple sclerosis	0.000129	0.000619	CcSEcCtD
Enalapril—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000129	0.000618	CcSEcCtD
Enalapril—Dizziness—Methylprednisolone—multiple sclerosis	0.000129	0.000618	CcSEcCtD
Enalapril—Feeling abnormal—Prednisone—multiple sclerosis	0.000127	0.00061	CcSEcCtD
Enalapril—Asthenia—Dexamethasone—multiple sclerosis	0.000127	0.00061	CcSEcCtD
Enalapril—Asthenia—Betamethasone—multiple sclerosis	0.000127	0.00061	CcSEcCtD
Enalapril—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000126	0.000605	CcSEcCtD
Enalapril—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000126	0.000605	CcSEcCtD
Enalapril—Nausea—Prednisolone—multiple sclerosis	0.000126	0.000605	CcSEcCtD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000126	0.00429	CbGpPWpGaD
Enalapril—Pruritus—Dexamethasone—multiple sclerosis	0.000125	0.000601	CcSEcCtD
Enalapril—Pruritus—Betamethasone—multiple sclerosis	0.000125	0.000601	CcSEcCtD
Enalapril—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000125	0.000598	CcSEcCtD
Enalapril—Vomiting—Triamcinolone—multiple sclerosis	0.000124	0.000595	CcSEcCtD
Enalapril—Vomiting—Methylprednisolone—multiple sclerosis	0.000124	0.000594	CcSEcCtD
Enalapril—Rash—Triamcinolone—multiple sclerosis	0.000123	0.00059	CcSEcCtD
Enalapril—Dermatitis—Triamcinolone—multiple sclerosis	0.000123	0.00059	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—RPL5—multiple sclerosis	0.000123	0.00419	CbGpPWpGaD
Enalapril—Anorexia—Methotrexate—multiple sclerosis	0.000123	0.000589	CcSEcCtD
Enalapril—Rash—Methylprednisolone—multiple sclerosis	0.000123	0.000589	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000123	0.00418	CbGpPWpGaD
Enalapril—Dermatitis—Methylprednisolone—multiple sclerosis	0.000123	0.000588	CcSEcCtD
Enalapril—Urticaria—Prednisone—multiple sclerosis	0.000122	0.000588	CcSEcCtD
Enalapril—Headache—Triamcinolone—multiple sclerosis	0.000122	0.000587	CcSEcCtD
Enalapril—Headache—Methylprednisolone—multiple sclerosis	0.000122	0.000585	CcSEcCtD
Enalapril—Abdominal pain—Prednisone—multiple sclerosis	0.000122	0.000585	CcSEcCtD
Enalapril—Body temperature increased—Prednisone—multiple sclerosis	0.000122	0.000585	CcSEcCtD
Enalapril—Diarrhoea—Dexamethasone—multiple sclerosis	0.000121	0.000581	CcSEcCtD
Enalapril—Diarrhoea—Betamethasone—multiple sclerosis	0.000121	0.000581	CcSEcCtD
Enalapril—Hypotension—Methotrexate—multiple sclerosis	0.00012	0.000578	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000117	0.000563	CcSEcCtD
Enalapril—Dizziness—Betamethasone—multiple sclerosis	0.000117	0.000562	CcSEcCtD
Enalapril—Dizziness—Dexamethasone—multiple sclerosis	0.000117	0.000562	CcSEcCtD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000117	0.00397	CbGpPWpGaD
Enalapril—Insomnia—Methotrexate—multiple sclerosis	0.000117	0.000559	CcSEcCtD
Enalapril—Nausea—Triamcinolone—multiple sclerosis	0.000116	0.000556	CcSEcCtD
Enalapril—Paraesthesia—Methotrexate—multiple sclerosis	0.000116	0.000555	CcSEcCtD
Enalapril—Nausea—Methylprednisolone—multiple sclerosis	0.000116	0.000555	CcSEcCtD
Enalapril—Dyspnoea—Methotrexate—multiple sclerosis	0.000115	0.000551	CcSEcCtD
Enalapril—Somnolence—Methotrexate—multiple sclerosis	0.000115	0.00055	CcSEcCtD
Enalapril—Hypersensitivity—Prednisone—multiple sclerosis	0.000114	0.000545	CcSEcCtD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000114	0.00387	CbGpPWpGaD
Enalapril—Dyspepsia—Methotrexate—multiple sclerosis	0.000113	0.000544	CcSEcCtD
Enalapril—Vomiting—Dexamethasone—multiple sclerosis	0.000113	0.00054	CcSEcCtD
Enalapril—Vomiting—Betamethasone—multiple sclerosis	0.000113	0.00054	CcSEcCtD
Enalapril—Decreased appetite—Methotrexate—multiple sclerosis	0.000112	0.000537	CcSEcCtD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000112	0.00381	CbGpPWpGaD
Enalapril—Rash—Betamethasone—multiple sclerosis	0.000112	0.000536	CcSEcCtD
Enalapril—Rash—Dexamethasone—multiple sclerosis	0.000112	0.000536	CcSEcCtD
Enalapril—Dermatitis—Dexamethasone—multiple sclerosis	0.000112	0.000535	CcSEcCtD
Enalapril—Dermatitis—Betamethasone—multiple sclerosis	0.000112	0.000535	CcSEcCtD
Enalapril—Fatigue—Methotrexate—multiple sclerosis	0.000111	0.000533	CcSEcCtD
Enalapril—Headache—Dexamethasone—multiple sclerosis	0.000111	0.000532	CcSEcCtD
Enalapril—Headache—Betamethasone—multiple sclerosis	0.000111	0.000532	CcSEcCtD
Enalapril—Asthenia—Prednisone—multiple sclerosis	0.000111	0.000531	CcSEcCtD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00011	0.00373	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000109	0.00373	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000109	0.00373	CbGpPWpGaD
Enalapril—Pruritus—Prednisone—multiple sclerosis	0.000109	0.000523	CcSEcCtD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000107	0.00366	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000106	0.00362	CbGpPWpGaD
Enalapril—Feeling abnormal—Methotrexate—multiple sclerosis	0.000106	0.00051	CcSEcCtD
Enalapril—Diarrhoea—Prednisone—multiple sclerosis	0.000105	0.000506	CcSEcCtD
Enalapril—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000105	0.000506	CcSEcCtD
Enalapril—Nausea—Dexamethasone—multiple sclerosis	0.000105	0.000505	CcSEcCtD
Enalapril—Nausea—Betamethasone—multiple sclerosis	0.000105	0.000505	CcSEcCtD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000105	0.00358	CbGpPWpGaD
Enalapril—Nateglinide—ALB—multiple sclerosis	0.000105	0.00828	CrCbGaD
Enalapril—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000103	0.00352	CbGpPWpGaD
Enalapril—Urticaria—Methotrexate—multiple sclerosis	0.000102	0.000491	CcSEcCtD
Enalapril—Dizziness—Prednisone—multiple sclerosis	0.000102	0.000489	CcSEcCtD
Enalapril—Abdominal pain—Methotrexate—multiple sclerosis	0.000102	0.000489	CcSEcCtD
Enalapril—Body temperature increased—Methotrexate—multiple sclerosis	0.000102	0.000489	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	9.89e-05	0.00337	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	9.81e-05	0.00334	CbGpPWpGaD
Enalapril—Vomiting—Prednisone—multiple sclerosis	9.8e-05	0.00047	CcSEcCtD
Enalapril—Rash—Prednisone—multiple sclerosis	9.72e-05	0.000466	CcSEcCtD
Enalapril—Dermatitis—Prednisone—multiple sclerosis	9.71e-05	0.000466	CcSEcCtD
Enalapril—Headache—Prednisone—multiple sclerosis	9.66e-05	0.000463	CcSEcCtD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.55e-05	0.00325	CbGpPWpGaD
Enalapril—Hypersensitivity—Methotrexate—multiple sclerosis	9.49e-05	0.000456	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—CD40—multiple sclerosis	9.43e-05	0.00321	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.3e-05	0.00317	CbGpPWpGaD
Enalapril—Asthenia—Methotrexate—multiple sclerosis	9.25e-05	0.000444	CcSEcCtD
Enalapril—Nausea—Prednisone—multiple sclerosis	9.16e-05	0.000439	CcSEcCtD
Enalapril—Pruritus—Methotrexate—multiple sclerosis	9.12e-05	0.000437	CcSEcCtD
Enalapril—ACE—Metabolism of proteins—BCHE—multiple sclerosis	8.99e-05	0.00306	CbGpPWpGaD
Enalapril—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.99e-05	0.00306	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.98e-05	0.00306	CbGpPWpGaD
Enalapril—Diarrhoea—Methotrexate—multiple sclerosis	8.82e-05	0.000423	CcSEcCtD
Enalapril—Dizziness—Methotrexate—multiple sclerosis	8.52e-05	0.000409	CcSEcCtD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	8.5e-05	0.00289	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.48e-05	0.00289	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.48e-05	0.00289	CbGpPWpGaD
Enalapril—Vomiting—Methotrexate—multiple sclerosis	8.19e-05	0.000393	CcSEcCtD
Enalapril—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.18e-05	0.00279	CbGpPWpGaD
Enalapril—Rash—Methotrexate—multiple sclerosis	8.12e-05	0.00039	CcSEcCtD
Enalapril—Dermatitis—Methotrexate—multiple sclerosis	8.12e-05	0.000389	CcSEcCtD
Enalapril—Headache—Methotrexate—multiple sclerosis	8.07e-05	0.000387	CcSEcCtD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.97e-05	0.00271	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.94e-05	0.0027	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	7.66e-05	0.00261	CbGpPWpGaD
Enalapril—Nausea—Methotrexate—multiple sclerosis	7.65e-05	0.000367	CcSEcCtD
Enalapril—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.55e-05	0.00257	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	7.51e-05	0.00256	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	7.51e-05	0.00256	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.5e-05	0.00256	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.41e-05	0.00252	CbGpPWpGaD
Enalapril—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.41e-05	0.00252	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.37e-05	0.00251	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.23e-05	0.00246	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.23e-05	0.00246	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.03e-05	0.0024	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—SRM—multiple sclerosis	6.91e-05	0.00236	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	6.88e-05	0.00234	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.7e-05	0.00228	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.67e-05	0.00227	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.48e-05	0.00221	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.44e-05	0.0022	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.37e-05	0.00217	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.3e-05	0.00215	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.92e-05	0.00202	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	5.82e-05	0.00198	CbGpPWpGaD
Enalapril—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.62e-05	0.00192	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.57e-05	0.0019	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.38e-05	0.00183	CbGpPWpGaD
Enalapril—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.31e-05	0.00181	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	4.87e-05	0.00166	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	4.87e-05	0.00166	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.79e-05	0.00163	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.76e-05	0.00162	CbGpPWpGaD
Enalapril—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.73e-05	0.00161	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.66e-05	0.00159	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—POMC—multiple sclerosis	4.65e-05	0.00158	CbGpPWpGaD
Enalapril—ACE—Metabolism of proteins—CCL2—multiple sclerosis	4.55e-05	0.00155	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—GPC5—multiple sclerosis	4.45e-05	0.00152	CbGpPWpGaD
Enalapril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.33e-05	0.00147	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.25e-05	0.00145	CbGpPWpGaD
Enalapril—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.2e-05	0.00143	CbGpPWpGaD
Enalapril—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.94e-05	0.00134	CbGpPWpGaD
Enalapril—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.92e-05	0.00134	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.79e-05	0.00129	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.78e-05	0.00129	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.74e-05	0.00127	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—RRM1—multiple sclerosis	3.69e-05	0.00126	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.63e-05	0.00124	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.2e-05	0.00109	CbGpPWpGaD
Enalapril—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.18e-05	0.00108	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—SRM—multiple sclerosis	2.96e-05	0.00101	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.95e-05	0.001	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.87e-05	0.000977	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.86e-05	0.000976	CbGpPWpGaD
Enalapril—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.86e-05	0.000974	CbGpPWpGaD
Enalapril—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.75e-05	0.000938	CbGpPWpGaD
Enalapril—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.7e-05	0.00092	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.54e-05	0.000864	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.46e-05	0.000838	CbGpPWpGaD
Enalapril—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.4e-05	0.000818	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.24e-05	0.000764	CbGpPWpGaD
Enalapril—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.13e-05	0.000727	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000722	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.00071	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.00071	CbGpPWpGaD
Enalapril—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2e-05	0.000683	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—GPC5—multiple sclerosis	1.91e-05	0.00065	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—SRM—multiple sclerosis	1.82e-05	0.000621	CbGpPWpGaD
Enalapril—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.69e-05	0.000576	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.000538	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.46e-05	0.000497	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.45e-05	0.000495	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.43e-05	0.000486	CbGpPWpGaD
Enalapril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.36e-05	0.000463	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.28e-05	0.000438	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.28e-05	0.000438	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000434	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.17e-05	0.0004	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.1e-05	0.000373	CbGpPWpGaD
Enalapril—SLCO1A2—Metabolism—ALB—multiple sclerosis	9.99e-06	0.00034	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.73e-06	0.000332	CbGpPWpGaD
Enalapril—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.13e-06	0.000311	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—BCHE—multiple sclerosis	9.07e-06	0.000309	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.59e-06	0.00019	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—APOE—multiple sclerosis	5.46e-06	0.000186	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—POMC—multiple sclerosis	4.69e-06	0.00016	CbGpPWpGaD
Enalapril—ABCB1—Metabolism—ALB—multiple sclerosis	4.28e-06	0.000146	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—APOE—multiple sclerosis	3.36e-06	0.000115	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—POMC—multiple sclerosis	2.89e-06	9.84e-05	CbGpPWpGaD
Enalapril—CYP3A4—Metabolism—ALB—multiple sclerosis	2.63e-06	8.98e-05	CbGpPWpGaD
